Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0001209191-22-057405

Options or other derivatives

  • Director acquired 35,235 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Shacham Sharon Director 2022-11-14 Grant or award · Stock Option (Right to Buy) +35,235 35,235 D
Loading xslF345X03/doc4.xml…